u/Twister699 · 2067d agono track record yet
CTXR Acute Respiratory Conditions help/cure worth billions
CTXR's stem-cell therapy for post-COVID acute respiratory conditions addresses a massive market of 76% of 117M+ hospitalized patients with lingering symptoms. The fast-tracked treatment combined with Mino-Lok launch will drive stock to all-time highs over the next year as a multi-billion dollar cash cow.
At post $48.00live price unavailable
1d-5.2%
3d-0.5%
1w-3.6%
1m-5.2%
3m+32.8%
6m+9.4%
1y-20.3%